Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Abciximab is a chimeric antibody fragment used as an antiplatelet drug targeting the αIIbβ3 integrin.
• Previous studies suggested abciximab binds to the β3 specificity-determining loop (SDL) and β1-α1 helix, but the mechanism of fibrinogen binding inhibition was unclear.

Purpose of the Study:

• To elucidate the structural basis of abciximab binding to αIIbβ3 and its mechanism of inhibiting fibrinogen binding.
• To resolve the interaction at high resolution using cryo-electron microscopy.

Main Methods:

• Cryo-electron microscopy (cryo-EM) to determine the structure of the αIIbβ3-abciximab complex at 2.8 Å resolution.
• Molecular-dynamics simulations and mutagenesis studies to validate cryo-EM findings.

Main Results:

• Abciximab binds to the β3 SDL, β1-α1 helix, and specific β3 residues, with unexpected interactions with αIIb.
• The binding does not disrupt the fibrinogen-binding pocket or rely on αIIb interactions.
• Abciximab binding compresses and reduces the flexibility of the β3 SDL.

Conclusions:

• Abciximab inhibits fibrinogen binding primarily through steric interference.
• The compression and reduced flexibility of the β3 SDL contribute to preventing ligand binding.